There is a particular kind of The Ordinary launch that exists mostly as a public science experiment. This is one of them. Volufiline has been quietly turning up in the middle of other brands' ingredient lists for more than a decade — usually at two or three percent, usually unnamed on the front of the bottle, usually supporting a more marketable hero like a peptide or a retinoid. Deciem's move here is to strip almost everything else away and let you see what a bottle of essentially just Volufiline does to your face over a couple of months. The 92% on the label is not really a concentration in the normal sense; it's closer to saying this formula is Volufiline and a few structural extras, full stop.
Open the dropper and the liquid is clear, slightly viscous, and scentless. It is technically an oil — the entire base is hydrogenated polyisobutene, a highly refined synthetic hydrocarbon that sits somewhere between squalane and a light silicone in feel — but it is noticeably less heavy than a traditional plant oil. Rhus succedanea wax gives it a touch of body so it doesn't run off the fingertips, caprylyl glycol and polyglyceryl-3 stearate help distribute the Anemarrhena extract through the oil phase, and tocopherol handles the oxidation housekeeping. That is the whole deck. No water, no preservatives, no actives competing for attention.
That minimalism is the point. Volufiline is a finicky ingredient to formulate with: it is oil-soluble, the extract it carries can oxidize, and emulsifying it into a traditional cream usually means cutting the load to a few percent and hoping it survives contact with water and surfactants. Going fully anhydrous sidesteps all of that. The active reaches skin in the form the manufacturer originally delivered it in, at a load the manufacturer's own research never quite tested, inside a vehicle that is itself an occlusive. If you are the sort of person who likes to know exactly what is doing the work, it is hard to argue with the honesty of the approach.
The case for Volufiline is that sarsasapogenin from Anemarrhena root can encourage lipid accumulation in isolated fat cells, which in a facial skin context is supposed to translate to a subtly plumper appearance where age-related volume loss has thinned the soft tissue. The case against it is that most of the supporting data is from the ingredient maker, sample sizes are small, and the visible effects in those studies are modest — millimeters and percentage changes, not the dramatic lift of a procedure. Both things can be true at once. Treating this serum as a long, slow experiment in lipid support is probably the right mental model; treating it as a filler replacement will set you up for disappointment.
In daily use it behaves well. Three or four drops pressed into cheeks and the upper neck after a hydrating serum sink in within a minute, leaving a satin finish rather than the greasy film a plant oil often produces. Layering sunscreen or makeup on top is uneventful if you don't overapply; go heavy and you'll get some slip. The first week's improvement is almost entirely the occlusion story — skin looks smoother and better hydrated because it is, and that by itself is a real visual upgrade for drier complexions. Whatever genuine plumping Volufiline is going to do on a given face tends to show up later, around the two-to-three-month mark of twice-daily use, and it is always a quiet change rather than a loud one.
Palmitoyl isoleucine at one percent is the other ingredient Deciem wants you to notice. It is a lipoamino acid rather than a signal peptide, which means it does not behave like a matrixyl or an argireline — it sits in the lipid matrix and is positioned as a supporting conditioner for the same adipocyte story. The honest read is that it is there partly for mechanism and partly for label: pairing Volufiline with a named secondary active is a more compelling product than Volufiline alone, even if the one percent level is modest. It does not hurt the formula and it plausibly helps, which is a reasonable bar to clear.
Where this serum shows its limits is in scope. The 15 mL bottle is small for twice-daily use on the full face and neck, and realistically you'll go through it in six to eight weeks. It is not a moisturizer on its own — skin that needs humectant hydration still needs a water-phase product underneath. And the subtlety of the effect means it is best thought of as an add-on to a well-built routine, not a centerpiece. If your routine is already doing the work of sunscreen, retinoids, and barrier support, this can layer in as a slow-burn plumping assist. If your routine is missing those fundamentals, spend the twenty-one dollars there first.
At the price, though, it is one of the easiest ingredient experiments to justify. Volufiline-forward products elsewhere typically sit north of forty dollars and deliver the active at a fraction of the load. If you wanted to know what Volufiline does to your face without any other variables in the way, this is now the cheapest and cleanest way to find out — which is, as always, the specific kind of useful The Ordinary is good at.
